CircaGene: Funding, Investors & Team (Oct 2026)
CircaGene is building the future of genetic testing. Direct to Consumer platform where users can order personal genetic tests through total privacy (Patented new encryption Number 1907358.4) with actionable results to reduce health Risk and enhance lifestyle and health. CircaGene provides End-to-end Encryption guaranteeing that only the user can have access to his results, protecting Genetic Privacy. Sequencing Services that put in relation Consumers with the best Genetic Research algorithms, easy to navigate reports, and connection to third parties with consistent healthcare. CircaGene can be described as the “Uber” of Genetic testing.
CircaGene has raised $200k across 1 funding round on record, the most recent an undisclosed round of $200k announced in Apr 2020.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CircaGene Company Profile and Key Stats
Latest funding round on record: Apr 2020.
CircaGene Funding Rounds
CircaGene Founders and Leadership Team
No contact details are on record for this team yet.
CircaGene Funding Compared to Other Biotechnology Startups
CircaGene's latest round of $200k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CircaGene in Biotechnology and London
Companies Similar to CircaGene
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
CircaGene Funding FAQs
What does CircaGene do?
CircaGene is building the future of genetic testing. Direct to Consumer platform where users can order personal genetic tests through total privacy (Patented new encryption Number 1907358.4) with actionable results to reduce health Risk and enhance lifestyle and health. CircaGene provides End-to-end Encryption guaranteeing that only the user can have access to his results, protecting Genetic Privacy. Sequencing Services that put in relation Consumers with the best Genetic Research algorithms, easy to navigate reports, and connection to third parties with consistent healthcare. CircaGene can be described as the “Uber” of Genetic testing.
How much funding has CircaGene raised?
CircaGene has raised $200k across 1 round on record. The most recent is an undisclosed round of $200k announced in Apr 2020.
When did CircaGene last raise funding?
CircaGene's most recent funding round on record is an undisclosed round of $200k, announced in Apr 2020.
Who is the CEO of CircaGene?
Francois Paillier is listed as CEO at CircaGene.
Where is CircaGene headquartered?
CircaGene is based in London, England, United Kingdom.
How many employees does CircaGene have?
CircaGene is in the 11-50 employee band.
How does CircaGene's funding compare to other Biotechnology startups?
CircaGene's latest round of $200k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CircaGene Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CircaGene is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.